Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial.

Name: Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial.
Author: Voskaridou, Ersi

Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial. — المؤلف: Voskaridou, Ersi — Blood advances 20190919

المؤلف: Voskaridou, Ersi
النشر: Blood advances 20190919
الوصف: 2837-2847 p.
الموضوعات: Adult؛ Aged؛ Bone Density؛ Bone Density Conservation Agents؛ Bone Remodeling؛ Collagen Type I؛ Denosumab؛ Double-Blind Method